Efficacy of Buccal Pad of Fat, Advanced Platelet Rich Fibrin, Fibrin Glue and Oxidized Cellulose Plug in Management of Oro-Antral Communication, Comparative Clinical Study

NCT ID: NCT06220877

Last Updated: 2024-01-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

24 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-01-01

Study Completion Date

2023-06-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Evaluation of the efficacy of different treatment protocols in the management of Oro-Antral Communications.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

the current study was carried on 24 patients suffering from Oro-Antral Communications. All patients were divided into 4 equal groups.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy Volunteers Only

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group I

patients were treated using Buccal Pad of Fat for management of OAC.

Group Type ACTIVE_COMPARATOR

Buccal Pad of Fat

Intervention Type PROCEDURE

surgical procedure

Group II

patients were treated using A-PRF technique for management of OAC.

Group Type ACTIVE_COMPARATOR

A-PRF

Intervention Type PROCEDURE

blood sample

Group III

patients were treated with Fibrin Glue for management of OAC.

Group Type ACTIVE_COMPARATOR

fibrin glue

Intervention Type PROCEDURE

procedure

Group IV

oxidized regenerated cellulose plug have been used for management of OAC.

Group Type ACTIVE_COMPARATOR

oxidized cellulose

Intervention Type PROCEDURE

procedure

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Buccal Pad of Fat

surgical procedure

Intervention Type PROCEDURE

A-PRF

blood sample

Intervention Type PROCEDURE

fibrin glue

procedure

Intervention Type PROCEDURE

oxidized cellulose

procedure

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patients suffering from oroantral communications
* patients suffering from oroantral fistula.
* The Diameter of the opening ranged from 4-9 mm,
* communication resulted from recent extraction,
* foreign body; or
* cyst enucleation

Exclusion Criteria

Patients suffering from any systemic diseases were excluded from the study.

* diabetes,
* autoimmune diseases,
* cancers,
* nephropathy,
* coagulation disorders
Minimum Eligible Age

20 Years

Maximum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

October 6 University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Nermine Ramadan Mahmoud

associate professor oral and maxillofacial surgery

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

October 6U

Cairo, , Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

RECO6U/19-2020

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.